DUBLIN--(BUSINESS WIRE)--The "Impact of COVID-19 on Global Digital PCR Industry" report has been added to ResearchAndMarkets.com's offering.
Global Digital PCR (dPCR) and Real-Time PCR (qPCR) products is expected to show a huge demand due to the COVID-19 pandemic all across the globe. PCR that is polymer chain reaction is an approach used for the detection of nucleic acid detection in order to measure the quantity of DNA or RNA in any specific sample. Considering the current pandemic situation of the COVID-19 outbreak, the tests delivered using the PCR method are proved to be more reliable and hence the acceptance of PCR is rising across the globe.
The factors that were fueling the growth of the dPCR and qPCR market before pandemic include the rising incidences of target infectious diseases coupled with genetic disorders. Additionally, the continuous technological advancements in the field of PCR technologies due to the increasing investments, funds, and grants by the government as well as non-government organizations were also fuelling the market growth. Moreover, the increased use of biomarker profiling for disease diagnostics and their successful completion of the human genome project was a major factor for the growth of the market globally.
With the outbreak of COVID-19 since December 2019, the dPCR and qPCR products have shown some promising results for the diagnosis of the disease. The use of dPCR and qPCR for the screening is offering physicians various advantages such as less time consumption, and more reliable results. The industry report is segmented based on technology and product type. By technology, the report is bifurcated into quantitative PCR and digital PCR whereas by product, the industry is studied into instruments, reagents & consumables, and software & services. Exponential growth in the demand for instruments and reagents has been witnessed in the COVID-19 affected countries for the faster diagnosis of the infected patients.
The demand for dPCR and qPCR due to pandemic can be observed in all regions such as North America, Europe, Asia-Pacific and the Rest of the World. In January & February 2020, most of the demand was from Asia-Pacific, however, an exponential surge is witnessed in March 2020 in Europe and North America due to a sudden rise in the COVID-19 cases in these regions. In the US, the FDA took some additional significant diagnostic actions due to the COVID-19 outbreak. For instance, on 16 March 2020, the FDA issued Emergency Use Authorizations (EUAs) to Laboratory Corporation of America (LabCorp) for its COVID-19 RT-PCR test.
- Abbott Laboratories Inc
- Agilent Technologies, Inc.
- Becton Dickinson and Company
- Bio-Rad Laboratories Inc.
- Biosciences Inc.
- BGI Group
- Eppendorf AG
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- Mylab Lifesolutions Pvt. Ltd.
- QIAGEN N.V.
- Thermo Fisher Scientific, Inc.
The Report Covers
- Comprehensive research methodology of the global dPCR and qPCR Industry.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global dPCR and qPCR Industry.
- Insights about market determinants that are stimulating the global Digital dPCR and qPCR Industry.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.3. Government support/expenditure for the dPCR & qPCR
2.4. Supply & Demand Analysis
3. Industry Overview
3.1. Historical market growth estimation in dPCR & qPCR industry pre-COVID-19 pandemic
3.2. Deviations in the dPCR & qPCR industry growth rate due to COVID-19 pandemic
4. Competitive Landscape
4.1. Company Share Analysis
4.2. Key Strategy Analysis
4.3. Key Company Analysis
4.3.2. Financial Analysis
4.3.3. SWOT Analysis
4.3.4. Recent Developments
5. Market Segmentation
5.1. By Technology
5.1.1. Quantitative PCR (qPCR)
5.1.2. Digital PCR (dPCR)
5.2. By Product
5.2.2. Reagents & Consumables
5.2.3. Software & Services
6. Regional Analysis
6.1. North America
6.1.1. United States
6.2.6. Rest of Europe
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/46near